Black Rose Industries Limited (BRIL) has reported a significant increase in revenue for the second quarter of fiscal year 2026, with both its manufacturing and distribution segments showing robust performance. The company's strategic initiatives and improved market conditions have contributed to this growth.

Financial Highlights

BRIL's Q2 FY26 financial performance showcases substantial growth compared to the previous quarter:

Segment-wise Performance

Manufacturing Division

The manufacturing segment demonstrated strong growth, with sales rising by 19% compared to the previous quarter. Key highlights include:

• Acrylamide liquid recorded significant growth, driven by strong domestic demand.
• Acrylamide solid maintained steady volumes.
• N-methylol acrylamide faced softer demand due to seasonal factors but maintained consistent momentum from key downstream sectors.

Distribution Division

The distribution business showed remarkable improvement:

• Turnover surged by 60% over the previous quarter.
• Growth was driven by robust supply support from key principals and higher volumes of core products such as ethanolamines, meta-cresol, and purified isophthalic acid.
• Merchant export volumes increased, supported by strategic alignment of offerings with customer requirements.

Key Financial Indicators

Outlook

The company expects improved performance in the upcoming quarter for both divisions:

• Manufacturing Division: Anticipated growth in acrylamide liquid exports, recovery in N-methylol acrylamide demand, and stable acrylamide solids performance.
• Distribution Division: Steady performance expected despite certain supply constraints, with plans to mitigate through new product additions and expanded market reach.

Projects and Expansions

BRIL continues to focus on innovation and long-term growth:

• The polyacrylamide solid R&D program is advancing towards the piloting phase.
• A feasibility study for the specialty amines project in collaboration with Koei Chemicals is progressing well.
• Environmental clearance for the specialty amines project is anticipated soon.
• Other new product development opportunities and toll-manufacturing projects are under active evaluation.

Black Rose Industries' strong performance in Q2 FY26 reflects its ability to capitalize on improved market conditions and strategic initiatives. The company's focus on both its manufacturing and distribution segments, coupled with ongoing R&D efforts, positions it well for continued growth in the Indian chemical industry.

Black Rose Industries Limited , a prominent player in the chemicals sector, has announced its financial results for the first quarter ended June 30, 2025, along with several significant corporate decisions. The company's Board of Directors approved these measures during a meeting held on August 14, 2025.

Financial Performance

For the quarter ended June 30, 2025, Black Rose Industries reported standalone revenue from operations of ₹59.85 crore, with a net profit of ₹4.24 crore. The company's performance reflects its continued operations in the chemical industry.

Key Management Changes

The Board has made several important decisions regarding the company's management structure:

1. Chief Risk Officer Appointment: Mr. Ratan Agrawal, the current Chief Financial Officer, has been appointed as the Chief Risk Officer of the company.

2. Senior Management Designations: Dr. Pavankumar Aduri, Vice President-Innovation, and Mr. Bhavesh Shah, General Manager-Sales, have been designated as Senior Management Personnel. This move is part of the reorganization of the company's Key Managerial Personnel structure.

Dr. Aduri brings over 16 years of experience in the chemical industry, with a Ph.D. in Chemical Engineering. He has been instrumental in driving innovation across specialty chemicals, polymer additives, liquid formulations, and pigments.

Mr. Shah, with over 30 years of experience, holds a Master's in Management Studies (Finance) from NMIMS and has been associated with the company since 2008, leading critical functions in marketing and sales.

Corporate Governance

The company has taken steps to strengthen its corporate governance:

1. Secretarial Auditor Appointment: M/s. Shiv Hari Jalan & Co., Practicing Company Secretaries, have been appointed as Secretarial Auditors for a term of 5 years (FY 2025-26 to FY 2029-30), subject to shareholder approval.

2. Annual General Meeting: The 35th Annual General Meeting is scheduled for September 29, 2025, to be held via video conferencing.

Strategic Business Decision

In a significant move, the Board has approved, subject to shareholder approval, the closure, sale, or transfer of 100% shareholding in its wholly-owned material subsidiary, B.R. Chemicals Co. Limited, Japan. This subsidiary contributed ₹54.37 crore, representing 13.57% of the total consolidated income of the company in the last financial year.

The decision follows the earlier move to discontinue the subsidiary's business operations from January 30, 2025. This strategic step is expected to impact the company's consolidated financial structure, as the subsidiary also contributed 3.67% to the total consolidated net worth.

Black Rose Industries continues to adapt to market conditions and streamline its operations, focusing on its core chemical business in India. The company's actions reflect its commitment to enhancing operational efficiency and shareholder value in the evolving business landscape.